Author:
Qiu Mingning,Chen Lieqian,Tan Guobin,Ke Longzhi,Zhang Sai,Chen Hege,Liu Jianjun
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Grimm, E. A., Sikora, A. G. & Ekmekcioglu, S. Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target. Clin Cancer Res 19, 5557–5563 (2013).
2. Huerta, S., Chilka, S. & Bonavida, B. Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33, 909–927 (2008).
3. Shami, P. J. et al. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol Cancer Ther 2, 409–417 (2003).
4. Kiziltepe, T. et al. JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood 110, 709–718 (2007).
5. Maciag, A. E. et al. The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species. J Pharmacol Exp Ther 336, 313–320 (2011).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献